No, BPC-157 is neither a hormone nor a steroid
However, some groups of people are more at risk of deficiency than others and may wish to discuss the possibility of B12 shots with their doctor
Poor sleep undermines peptide therapy effectiveness
Beyond GLP-1, the market encompasses peptide cancer therapies (Oncology Peptide Therapy at 4.1% share, 11.79% CAGR), somatostatin analogues for neuroendocrine tumours, GnRH agonists/antagonists for hormone-sensitive cancers, radioligand therapy, and reproductive medicine peptides each representing strategically important niches with their own competitive dynamics
the "PDA counterion argument" for regulatory compliance has not been validated by FDA guidance as of April 2026
Yes B12 pairs well with both NAD+ injections and our GLP-1 medical weight loss program